{"doi":"10.1038/s41375-021-01431-x","title":"Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial","abstract":null,"journal":"Leukemia","year":2022,"id":627131,"datarank":0.6535063240034389,"base_score":4.356708826689592,"endowment":4.356708826689592,"self_citation_contribution":0.6535063240034389,"citation_network_contribution":0.0,"self_endowment_contribution":0.6535063240034389,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":77,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1622666,"name":"Britta Besemer","orcid":null,"position":1,"is_corresponding":false},{"id":1622667,"name":"Anne Marie Asemissen","orcid":null,"position":2,"is_corresponding":false},{"id":1472822,"name":"Mathias Hänel","orcid":"0000-0002-4767-3275","position":3,"is_corresponding":false},{"id":1553842,"name":"Igor Wolfgang Blau","orcid":null,"position":4,"is_corresponding":false},{"id":1622668,"name":"Martin Görner","orcid":null,"position":5,"is_corresponding":false},{"id":306372,"name":"Yon-Dschun Ko","orcid":null,"position":6,"is_corresponding":false},{"id":332516,"name":"Hans Christian Reinhardt","orcid":"0000-0001-5706-9349","position":7,"is_corresponding":false},{"id":14084,"name":"Peter Staib","orcid":null,"position":8,"is_corresponding":false},{"id":1622669,"name":"Christoph Mann","orcid":null,"position":9,"is_corresponding":false},{"id":853564,"name":"Raphael Lutz","orcid":null,"position":10,"is_corresponding":false},{"id":1622670,"name":"Markus Munder","orcid":null,"position":11,"is_corresponding":false},{"id":1622671,"name":"Ullrich Graeven","orcid":"0000-0001-6082-7710","position":12,"is_corresponding":false},{"id":1622672,"name":"Rudolf Peceny","orcid":null,"position":13,"is_corresponding":false},{"id":229112,"name":"Hans Salwender","orcid":"0000-0001-7803-0814","position":14,"is_corresponding":false},{"id":888248,"name":"Anna Jauch","orcid":"0000-0002-0771-3084","position":15,"is_corresponding":false},{"id":1622673,"name":"Manola Zago","orcid":null,"position":16,"is_corresponding":false},{"id":409717,"name":"Axel Benner","orcid":"0000-0002-7238-6956","position":17,"is_corresponding":false},{"id":1622674,"name":"Diana Tichy","orcid":null,"position":18,"is_corresponding":false},{"id":1240535,"name":"Carsten Bokemeyer","orcid":"0000-0001-6071-7810","position":19,"is_corresponding":false},{"id":282798,"name":"Hartmut Goldschmidt","orcid":"0000-0003-0961-0035","position":20,"is_corresponding":false},{"id":1357560,"name":"Katja Weisel","orcid":"0000-0001-9422-6614","position":21,"is_corresponding":false},{"id":1622665,"name":"Lisa B. Leypoldt","orcid":"0000-0002-9248-588X","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial","abstract":null,"is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"34732857","pmcid":null,"openalex_id":null,"authors":[],"funders":[],"total_grants":0,"fwci":null,"citation_percentile":null,"influential_citations":0,"citation_trend":[],"oa_status":"hybrid","license":"cc-by","oa_locations":[{"url":"https://www.nature.com/articles/s41375-021-01431-x.pdf","host_type":"publisher"},{"url":"https://www.nature.com/articles/s41375-021-01431-x","host_type":"publisher"},{"url":"https://repository.publisso.de/resource/frl:6443784","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8885414","host_type":"repository"}],"fields_of_study":["Adult","Aged","Aged, 80 and over","Antibodies, Monoclonal, Humanized","Antineoplastic Combined Chemotherapy Protocols","Dexamethasone","Female","Humans","Lenalidomide","Male","Middle Aged","Multiple Myeloma","Oligopeptides","Progression-Free Survival"],"mesh_terms":["Adult","Aged","Aged, 80 and over","Antibodies, Monoclonal, Humanized","Antineoplastic Combined Chemotherapy Protocols","Dexamethasone","Female","Humans","Lenalidomide","Male","Middle Aged","Multiple Myeloma","Oligopeptides","Progression-Free Survival"],"keywords":[],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-04T16:19:48.225378Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}